Ellis Pharma, which was the original foundation of Bionical, was a global supplier of commercial pharmaceutical products to meet regional market shortages to facilitate continuous care for patients.
In 2015 we acquired US-based, McCallan Healthcare, a company focused on personalised patient care through the means of innovative multi-channel marketing programs such as MED Select™ see our products.
2015 also saw the acquisition of UK-based North 51 whose services deliver patient, doctor and payer engagement. North 51 added market leading public health and lifestyle services, contract sales solutions, digital and creative services and market insight and research expertise. The acquisition also added widely used public health technologies such as Quit Manager and IPAS to the Bionical offering.
2016 saw our most recent acquisition - read more here